US · Healthcare

Palvella Therapeutics, Inc (PVLA)

Biotechnology

Palvella Therapeutics, Inc (PVLA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PVLA

P/E ratio

18.00

Palvella Therapeutics, Inc (PVLA) — FAQ

What is PVLA's P/E ratio?

The price-to-earnings (P/E) ratio for Palvella Therapeutics, Inc (PVLA) is 18.00 (data as of 2026-03-24).

Does Palvella Therapeutics, Inc pay a dividend?

Dividend yield is not available in the current snapshot for Palvella Therapeutics, Inc (PVLA). Check the MyAverix Finance app for the latest dividend data.

What sector is Palvella Therapeutics, Inc in?

Palvella Therapeutics, Inc (PVLA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PVLA listed on?

PVLA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)